Omega Healthcare Investors (NYSE:OHI) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Omega Healthcare Investors (NYSE:OHI – Free Report) from a hold rating to a buy rating in a research report sent to investors on Saturday morning,Wall Street Zen reports.

Several other brokerages have also issued reports on OHI. Wells Fargo & Company lowered their target price on Omega Healthcare Investors from $49.00 to $48.00 and set an “equal weight” rating for the company in a research report on Tuesday, September 1st. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Omega Healthcare Investors in a report on Friday, September 25th. Mizuho upped their price target on Omega Healthcare Investors from $45.00 to $46.00 and gave the company a “neutral” rating in a research report on Monday, August 31st. Raymond James Financial reiterated an “outperform” rating and issued a $53.00 price target on shares of Omega Healthcare Investors in a research report on Tuesday, October 6th. Finally, UBS Group decreased their price target on Omega Healthcare Investors from $54.00 to $52.00 and set a “buy” rating for the company in a research note on Tuesday, October 13th. Six investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $49.79.

Read Our Latest Report on Omega Healthcare Investors

Omega Healthcare Investors Stock Performance

OHI stock opened at $44.92 on Friday. The company has a fifty day moving average price of $46.19 and a 200-day moving average price of $46.93. The company has a market capitalization of $13.61 billion, a P/E ratio of 14.09, a PEG ratio of 1.84 and a beta of 0.53. Omega Healthcare Investors has a 52-week low of $39.26 and a 52-week high of $52.39.

Omega Healthcare Investors (NYSE:OHI – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.68. The company had revenue of $328.25 million for the quarter, compared to analyst estimates of $266.97 million. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. Omega Healthcare Investors’s revenue was up 16.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.77 earnings per share. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. As a group, sell-side analysts forecast that Omega Healthcare Investors will post 3.12 earnings per share for the current fiscal year.

Omega Healthcare Investors Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Monday, August 3rd were issued a dividend of $0.68 per share. This represents a $2.72 annualized dividend and a yield of 6.1%. The ex-dividend date was Monday, August 3rd. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.67. Omega Healthcare Investors’s dividend payout ratio (DPR) is 97.14%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of OHI. Amundi increased its position in Omega Healthcare Investors by 100.4% in the 2nd quarter. Amundi now owns 1,125,875 shares of the real estate investment trust’s stock valued at $53,682,000 after buying an additional 564,175 shares in the last quarter. Oxbow Advisors LLC bought a new position in Omega Healthcare Investors in the first quarter worth approximately $7,373,000. Y Intercept Hong Kong Ltd boosted its holdings in Omega Healthcare Investors by 351.4% in the first quarter. Y Intercept Hong Kong Ltd now owns 42,368 shares of the real estate investment trust’s stock worth $1,857,000 after acquiring an additional 32,982 shares in the last quarter. AlphaGrep UK Ltd bought a new position in Omega Healthcare Investors in the second quarter worth approximately $1,246,000. Finally, Greenland Capital Management LP acquired a new stake in Omega Healthcare Investors in the second quarter valued at approximately $7,867,000. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

(Get Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust focused on the healthcare sector. The company invests in and owns healthcare facilities, with a primary emphasis on skilled nursing and assisted living properties.

Omega generally leases its properties to healthcare operators under long-term agreements, supporting services for seniors and individuals who require post-acute, rehabilitative, or long-term care. Its portfolio has also included other healthcare-related properties, such as continuing care retirement communities and specialty facilities.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega serves healthcare operators across the United States and the United Kingdom.

Further Reading

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.